DIFFERENTIAL CLEAVAGE OF URODILATIN AND ATRIAL-NATRIURETIC-FACTOR BY THROMBIN AND PROTEASE 3.4.24.11

被引:1
作者
BERRY, C [1 ]
SAKANE, Y [1 ]
RAMANNAN, R [1 ]
KRULAN, C [1 ]
BALWIERCZAK, J [1 ]
GHAI, R [1 ]
机构
[1] CIBA GEIGY CORP,RES DEPT,DIV PHARMACEUT,SUMMIT,NJ 07901
来源
JOURNAL OF ENZYME INHIBITION | 1993年 / 7卷 / 04期
关键词
URODILATIN; H-ANF; NEUTRAL ENDOPEPTIDASE 3.4.24.11; CLEAVAGE SITE;
D O I
10.3109/14756369309040768
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human urodilatin (residues 95-126) and atrial natriuretic factor (residues 99-126, based on ANF prohormone sequence) were incubated separately with three proteases, thrombin, angiotensin converting enzyme (ACE), and neutral endopeptidase 3.4.24.11 (NEP). Thrombin cleaved urodilatin on the carboxyl side of arginine(98) to yield ANF but under the same conditions did not cleave h-ANE Neither urodilatin nor ANF was cleaved by ACE. ANF was rapidly degraded by NEP resulting in a major product cleaved between amino acid residues Cys(105) and Phe(106). Urodilatin was also cleaved by NEP and the amino acid sequencing of the cleaved product revealed the site of cleavage to be the same Cys(105)-Phe(106) site as for ANF with a second cleavage site at Gly(118)-Leu(119). However, cleavage of urodilatin by NEP proceeded much more slowly when compared to ANF A comparison of the affinities of ANF and urodilatin for purified NEP from rabbit kidney revealed K-m Values of 11.7 and 3.1 mu M, respectively. The turnover rates (k(cat)/K-m) for urodilatin and h-ANF with NEP were 4.6 and 37.3 min(-1) mu M, respectively. Thus, urodilatin is much less efficiently hydrolyzed by purified NEP than is ANF The four residue extension at the N-terminus of urodilatin may be important for protection against rapid biological inactivation.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 19 条
[1]   PHOSPHORYLATION AND DEPHOSPHORYLATION OF THE NATRIURETIC PEPTIDE URODILATIN (CDD-95-126 ANP-95-126) AND THE EFFECT ON BIOLOGICAL-ACTIVITY [J].
DORNER, T ;
GAGELMANN, M ;
FELLER, S ;
HERBST, F ;
FORSSMANN, WG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 163 (02) :830-835
[2]  
DRUMMER C, 1991, J AM SOC NEPHROL, V1, P1109
[3]   URODILATIN - A NEWLY DESCRIBED MEMBER OF THE ANP FAMILY [J].
FELLER, SM ;
GAGELMANN, M ;
FORSSMANN, WG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (03) :93-94
[4]  
GAGLEMAN M, 1988, FEBS LETT, V233, P249
[5]  
Ghai R D, 1991, J Enzyme Inhib, V4, P267, DOI 10.3109/14756369109035850
[6]   RENAL NATRIURETIC PEPTIDE (URODILATIN QUESTIONABLE) AND ATRIOPEPTIN - EVOLVING CONCEPTS [J].
GOETZ, KL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (06) :F921-F932
[7]   COMPARISON OF RENAL ACTIONS OF URODILATIN AND ATRIAL-NATRIURETIC-PEPTIDE [J].
HILDEBRANDT, DA ;
MIZELLE, HL ;
BRANDS, MW ;
HALL, JE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03) :R395-R399
[8]   ATRIAL-NATRIURETIC-FACTOR AND HYPERTENSION - A REVIEW AND METAANALYSIS [J].
HOLLISTER, AS ;
INAGAMI, T .
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (10) :850-865
[9]  
KOEHN JA, 1987, J BIOL CHEM, V262, P11623
[10]  
KREITER PA, 1989, DRUG METAB DISPOS, V17, P14